BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10354290)

  • 1. Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report.
    Gaber LW; Moore LW; Gaber AO; Tesi RJ; Meyer J; Schroeder TJ
    Kidney Int; 1999 Jun; 55(6):2415-22. PubMed ID: 10354290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
    Gaber AO; First MR; Tesi RJ; Gaston RS; Mendez R; Mulloy LL; Light JA; Gaber LW; Squiers E; Taylor RJ; Neylan JF; Steiner RW; Knechtle S; Norman DJ; Shihab F; Basadonna G; Brennan DC; Hodge EE; Kahan BD; Kahan L; Steinberg S; Woodle ES; Chan L; Ham JM; Schroeder TJ
    Transplantation; 1998 Jul; 66(1):29-37. PubMed ID: 9679818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymoglobulin reverses acute renal allograft rejection better than ATGAM--a double-blinded randomized clinical trial.
    Tesi RJ; Kano JM; Horn HR; Schroeder T
    Transplant Proc; 1997 Nov; 29(7A):21S-23S. PubMed ID: 9366922
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.
    Brennan DC; Flavin K; Lowell JA; Howard TK; Shenoy S; Burgess S; Dolan S; Kano JM; Mahon M; Schnitzler MA; Woodward R; Irish W; Singer GG
    Transplantation; 1999 Apr; 67(7):1011-8. PubMed ID: 10221486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economics of the antithymocyte globulins Thymoglobulin and Atgam in the treatment of acute renal transplant rejection.
    Schnitzler MA; Woodward RS; Lowell JA; Amir L; Schroeder TJ; Singer GG; Brennan DC
    Pharmacoeconomics; 2000 Mar; 17(3):287-93. PubMed ID: 10947303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between Banff classification, acute renal rejection scores, and reversal of rejection.
    Gaber LW; Moore LW; Alloway RR; Flax S; Gaber AO
    Transplant Proc; 1995 Feb; 27(1):1019. PubMed ID: 7878784
    [No Abstract]   [Full Text] [Related]  

  • 7. The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design.
    Schroeder TJ; Moore LW; Gaber LW; Gaber AO; First MR
    Transplant Proc; 1999 May; 31(3B Suppl):1S-6S. PubMed ID: 10330958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation of Banff scoring with reversibility of first and recurrent rejection episodes.
    Gaber LW; Schroeder TJ; Moore LW; Shakouh-Amiri MH; Gaber AO
    Transplantation; 1996 Jun; 61(12):1711-5. PubMed ID: 8685948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal allograft rejection with intimal arteritis: histologic predictors of response to therapy and graft survival.
    Haas M; Kraus ES; Samaniego-Picota M; Racusen LC; Ni W; Eustace JA
    Kidney Int; 2002 Apr; 61(4):1516-26. PubMed ID: 11918760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
    Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
    Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-Center Study Group.
    Regan JF; Campbell K; Van Smith L; Schroeder TJ; Womble D; Kano J; Buelow R
    Transpl Immunol; 1999 Jun; 7(2):115-21. PubMed ID: 10544442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreas allograft rejection: analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies.
    Troxell ML; Koslin DB; Norman D; Rayhill S; Mittalhenkle A
    Transplantation; 2010 Jul; 90(1):75-84. PubMed ID: 20548259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.
    Hardinger KL; Schnitzler MA; Miller B; Lowell JA; Shenoy S; Koch MJ; Enkvetchakul D; Ceriotti C; Brennan DC
    Transplantation; 2004 Jul; 78(1):136-41. PubMed ID: 15257052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference.
    Gaber LW; Moore LW; Gaber AO; First MR; Guttmann RD; Pouletty P; Schroeder TJ; Soulillou JP
    Transplantation; 1998 Feb; 65(3):376-80. PubMed ID: 9484754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of the nuclear factor-κB pathway by rabbit antithymocyte globulins in kidney transplantation.
    Urbanova M; Brabcova I; Girmanova E; Zelezny F; Viklicky O
    Transplantation; 2012 Mar; 93(6):589-96. PubMed ID: 22334040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts.
    Alamartine E; Bellakoul R; Berthoux F
    Transplant Proc; 1994 Feb; 26(1):273-4. PubMed ID: 8108975
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation between the Banff 97 classification of renal allograft biopsies and clinical outcome.
    Tanaka T; Kyo M; Kokado Y; Takahara S; Hatori M; Suzuki K; Hasumi M; Toki K; Ichimaru N; Yazawa K; Hanafusa T; Namba Y; Oka K; Moriyama T; Imai E; Okuyama A; Yamanaka H
    Transpl Int; 2004 Feb; 17(2):59-64. PubMed ID: 14551678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of accelerated renal allograft rejection with FK 506.
    Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR
    Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Banff criteria as predictors of outcome following acute renal allograft rejection.
    Macdonald FI; Ashraf S; Picton M; Dyer PA; Parrott NR; Short CD; Roberts IS
    Nephrol Dial Transplant; 1999 Jul; 14(7):1692-7. PubMed ID: 10435878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.